New Zealand markets closed

Rennova Health, Inc. (RNVA)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0001+0.0001 (+9,900.00%)
As of 10:40AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.06M
Enterprise value 16.17M
Trailing P/E 0.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.89
Price/book (mrq)N/A
Enterprise value/revenue 0.80
Enterprise value/EBITDA 3.03

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 30.00%
S&P500 52-week change 329.57%
52-week high 30.0002
52-week low 30.0000
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 359.55M
Avg vol (10-day) 38.99M
Shares outstanding 540.55B
Implied shares outstanding 629.93B
Float 8N/A
% held by insiders 10.00%
% held by institutions 16.69%
Shares short (13 Oct 2017) 4N/A
Short ratio (13 Oct 2017) 40.84
Short % of float (13 Oct 2017) 48.21%
Short % of shares outstanding (13 Oct 2017) 48.10%
Shares short (prior month 15 Sept 2017) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 303 Aug 2020
Ex-dividend date 4N/A
Last split factor 21:10000
Last split date 316 Mar 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 11.60%
Operating margin (ttm)-16.99%

Management effectiveness

Return on assets (ttm)11.35%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)20.3M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)25.20%
Gross profit (ttm)N/A
EBITDA 4.01M
Net income avi to common (ttm)2.38M
Diluted EPS (ttm)0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)123.9k
Total cash per share (mrq)0
Total debt (mrq)12.24M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.12
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)4.05M
Levered free cash flow (ttm)1.53M